Kingfa Science

  • Market Cap: Small Cap
  • Industry: Plastic Products - Industrial
  • ISIN: INE473D01015
  • NSEID: KINGFA
  • BSEID: 524019
INR
3,950.00
-49.45 (-1.24%)
BSENSE

Dec 05

BSE+NSE Vol: 1.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.72 k (32.45%) Volume

Shareholding (Sep 2025)

FII

7.78%

Held by 7 FIIs

DII

2.20%

Held by 7 DIIs

Promoter

67.02%

What does Kingfa Science do?

06-Jun-2025

Kingfa Science & Technology (India) Ltd is a small-cap company in the plastic products industry, reporting net sales of ₹470 Cr and a net profit of ₹42 Cr for Q1 2025. The company, formerly Hydro S&S Industries, has a market cap of ₹3,907 Cr and key metrics include a P/E of 26.00 and a dividend yield of 0.31%.

Overview:<BR>Kingfa Science & Technology (India) Ltd operates in the plastic products industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in November 1983 as Hydro S&S Industries Limited and was renamed to Kingfa Science & Technology (India) Limited in December 2015. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 470 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 42 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 3,907 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 26.00<BR>- Industry P/E: 41<BR>- Dividend Yield: 0.31%<BR>- Debt-Equity: 0.03<BR>- Return on Equity: 20.98%<BR>- Price to Book: 5.45<BR><BR>Contact Details:<BR>Address: Dhun Building III Floor, 827 Anna Salai Chennai Tamil Nadu : 600002<BR>Tel: 91-44-28521736 (4 lines)<BR>Email: cs@kingfaindia.com<BR>Website: http://www.hssil.com

Read More

Has Kingfa Science declared dividend?

06-Jun-2025

Yes, Kingfa Science & Technology (India) Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of September 17, 2024. The company has shown strong long-term performance, with a total return of 626.88% over the last 5 years.

Kingfa Science & Technology (India) Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 17 Sep 24<BR><BR>Dividend Yield: 0.31%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -2.21%, with a dividend return of 0%, resulting in a total return of -2.21%.<BR><BR>Over the 1-year period, the price return was 65.65%, the dividend return was 0.53%, leading to a total return of 66.18%.<BR><BR>For the 2-year period, the price return was 60.17%, with a dividend return of 0.51%, culminating in a total return of 60.68%.<BR><BR>In the 3-year span, the price return reached 238.32%, while the dividend return was 1.28%, resulting in a total return of 239.6%.<BR><BR>During the 4-year period, the price return was 202.84%, with a dividend return of 1.00%, leading to a total return of 203.84%.<BR><BR>Over the last 5 years, the price return was 624.41%, and the dividend return was 2.47%, resulting in a total return of 626.88%.<BR><BR>Overall, Kingfa Science has declared a significant dividend, and while the recent returns show some volatility, the long-term performance appears strong, particularly over the 5-year period.

Read More

Who are the peers of the Kingfa Science?

03-Jun-2025

Kingfa Science's peers include Supreme Inds., Astral, Finolex Inds., Garware Hi Tech, Shaily Engineer, Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes. Kingfa Science has average management risk and growth, with a 1-year return of 74.77%, while peers show varying management risks and returns.

Peers: The peers of Kingfa Science are Supreme Inds., Astral, Finolex Inds., Garware Hi Tech, Shaily Engineer., Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes.<BR><BR>Quality Snapshot: Excellent management risk is observed at Supreme Inds. and the rest. Good management risk is found at Astral, Finolex Inds., Shaily Engineer., Prince Pipes, and Apollo Pipes, while Average management risk is present at Garware Hi Tech, Kingfa Science, and Prakash Pipes. Below Average management risk is noted for Jain Irrigation and Jai Corp. Growth is Average at Garware Hi Tech, while Good growth is seen at Astral, Shaily Engineer., Kingfa Science, Jain Irrigation, and the rest. Below Average growth is found at Finolex Inds. and Prince Pipes, while Jai Corp has Below Average growth. Excellent capital structure is noted at Supreme Inds., Finolex Inds., Garware Hi Tech, Kingfa Science, and the rest, while Good capital structure is seen at Shaily Engineer. Below Average capital structure is present at Jain Irrigation and Jai Corp.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Shaily Engineer. at 199.86%, while the lowest is Finolex Inds. at -34.87%. Kingfa Science's 1-year return of 74.77% is significantly higher than that of Finolex Inds. Negative six-month returns are noted for Supreme Inds., Astral, Finolex Inds., Jain Irrigation, Prince Pipes, Apollo Pipes, Jai Corp, and Prakash Pipes.

Read More

Who are in the management team of Kingfa Science?

16-Jul-2025

As of March 2023, the management team of Kingfa Science includes Bo Jingen, D Balaji, Wu Xiaohui (executive directors), and independent directors Narayanaswamy Subramanian, Dilip Dinkar Kulkarni, and Nilima Ramrao Shinde. Their remuneration ranges from 3.2 to 89.03 lacs INR.

As of March 2023, the management team of Kingfa Science includes the following members:<BR><BR>1. Bo Jingen - Non Independent Executive Director, with a remuneration of 26.91 lacs INR.<BR>2. D Balaji - Executive Non Independent Director, with a remuneration of 89.03 lacs INR.<BR>3. NARAYANASWAMY SUBRAMANIAN - Independent Non Executive Director, with a remuneration of 7.2 lacs INR.<BR>4. Dilip Dinkar Kulkarni - Independent Non Executive Director, with a remuneration of 7.8 lacs INR.<BR>5. Nilima Ramrao Shinde - Independent Non Executive Director, with a remuneration of 7.8 lacs INR.<BR>6. Wu Xiaohui - Non Independent Executive Director, with a remuneration of 3.2 lacs INR. <BR><BR>This team comprises both executive and independent directors, contributing to the governance and strategic direction of the company.

Read More

Who are the top shareholders of the Kingfa Science?

17-Jul-2025

The top shareholders of Kingfa Science include Kingfa Sci. & Tech. Co. Ltd. with 74.99%, Hongkong Victory Investment Co Limited at 6.32%, and Foreign Institutional Investors holding 6.35%. Individual investors collectively own 15.31%, while mutual funds have a minimal stake of 0.04%.

The top shareholders of Kingfa Science include the following:<BR><BR>1. **Kingfa Sci. & Tech. Co. Ltd.** - This entity holds the largest share, with a significant 74.99% stake in the company.<BR>2. **Hongkong Victory Investment Co Limited** - This is the highest public shareholder, owning 6.32% of the shares.<BR>3. **Foreign Institutional Investors (FIIs)** - A total of 6 FIIs collectively hold 6.35%.<BR>4. **Mutual Funds** - There is minimal representation from mutual funds, with just 0.04% held by one scheme.<BR>5. **Individual Investors** - They hold a combined 15.31% of the shares.<BR><BR>Overall, the majority ownership is concentrated with the promoters, particularly Kingfa Sci. & Tech. Co. Ltd.

Read More

When is the next results date for Kingfa Science?

24-Jul-2025

The next results date for Kingfa Science is July 30, 2025.

The next results date for Kingfa Science is scheduled for July 30, 2025.

Read More

How big is Kingfa Science?

24-Jul-2025

As of 24th July, Kingfa Science & Technology (India) Ltd has a market capitalization of 4,439.00 Cr, with recent net sales of 1,744.69 Cr and a net profit of 152.86 Cr. Shareholder's funds are 588.58 Cr, and total assets are valued at 994.44 Cr.

As of 24th July, Kingfa Science & Technology (India) Ltd has a market capitalization of 4,439.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 1,744.69 Cr and a Net Profit of 152.86 Cr.<BR><BR>For the latest annual period ending March 2024, the Shareholder's Funds amounted to 588.58 Cr, while the Total Assets were valued at 994.44 Cr.

Read More

Is Kingfa Science technically bullish or bearish?

04-Nov-2025

As of November 3, 2025, Kingfa Science's trend is mildly bullish, supported by a bullish MACD and moving averages, though tempered by a mildly bearish KST and Dow Theory indicators.

As of 3 November 2025, the technical trend for Kingfa Science has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on both weekly and monthly time frames, along with bullish daily moving averages. However, the KST indicates a mildly bearish monthly trend, and Dow Theory shows a mildly bearish weekly stance, which tempers the overall bullish outlook. The Bollinger Bands are also mildly bullish on both weekly and monthly charts. Despite recent price fluctuations, the stock has shown strong returns over various periods, particularly in the long term.

Read More

How has been the historical performance of Kingfa Science?

13-Nov-2025

Kingfa Science has shown consistent growth, with net sales increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25, and significant improvements in profitability, total assets, and cash flow. Key metrics like profit after tax rose from 5.32 Cr to 152.86 Cr during the same period, reflecting strong operational efficiency.

Answer:<BR>The historical performance of Kingfa Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Kingfa Science has demonstrated significant growth in net sales, increasing from 627.24 Cr in Mar'21 to 1,744.69 Cr in Mar'25. This upward trend is mirrored in total operating income, which rose from 741.50 Cr in Mar'20 to 1,744.69 Cr in Mar'25. The company's operating profit (PBDIT) also saw a substantial increase, reaching 234.45 Cr in Mar'25, up from just 25.96 Cr in Mar'21. Profit before tax followed suit, climbing to 206.08 Cr in Mar'25 from 11.85 Cr in Mar'21, while profit after tax reached 152.86 Cr in Mar'25, a significant rise from 5.32 Cr in Mar'21. The company's total assets grew from 596.30 Cr in Mar'20 to 1,155.62 Cr in Mar'25, reflecting a robust expansion in its financial base. Additionally, the book value per share has increased from 287.84 in Mar'20 to 601.63 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities improved markedly, reaching 59.00 Cr in Mar'25, compared to a negative cash flow in Mar'21. Overall, Kingfa Science's financial performance illustrates a strong upward trend across key metrics, highlighting its growth and operational efficiency.

Read More

Are Kingfa Science latest results good or bad?

13-Nov-2025

Kingfa Science's latest results show steady revenue growth with net sales up 11.32% year-on-year, but profitability concerns arise from a slight decline in operating and PAT margins, indicating potential cost pressures. Investors should monitor these factors for future performance insights.

Kingfa Science's latest results present a mixed picture. On the positive side, the company reported net sales of ₹465.69 crores for Q2 FY26, which reflects a quarter-on-quarter increase of 0.81% and a year-on-year growth of 11.32%. This indicates steady demand in the industrial plastics segment, showcasing the company's ability to maintain revenue growth even in a challenging market.<BR><BR>However, there are concerns regarding profitability. The operating margin has contracted to 13.01%, down from 13.35% in the same quarter last year, suggesting that the company is facing cost pressures that could impact its pricing power. Additionally, while net profit increased to ₹41.14 crores, the profit after tax (PAT) margin slightly decreased to 8.83% from 8.91% year-on-year.<BR><BR>Overall, while the revenue growth is encouraging, the margin compression raises questions about the company's cost management and profitability sustainability. Investors should keep an eye on these dynamics as they assess the company's performance moving forward.

Read More

Should I buy, sell or hold Kingfa Science?

14-Nov-2025

Is Kingfa Science overvalued or undervalued?

04-Dec-2025

As of December 3, 2025, Kingfa Science is fairly valued with a PE ratio of 34.86, lower than some peers like Supreme Industries and Astral, but higher than Finolex Industries, and has delivered a strong 200% return over three years compared to the Sensex's 35.37%.

As of 3 December 2025, Kingfa Science has moved from an expensive to a fair valuation grade. The company appears to be fairly valued at this time. Key ratios include a PE ratio of 34.86, an EV to EBITDA of 23.91, and a ROE of 21.61%. <BR><BR>In comparison to peers, Kingfa Science's PE ratio is lower than Supreme Industries at 49.49 and Astral at 74.25, both of which are classified as expensive. Additionally, Finolex Industries, which is also rated fair, has a significantly lower PE ratio of 22.26, indicating that Kingfa Science is relatively more expensive than some of its peers. Despite a recent decline in stock price, Kingfa Science has shown strong long-term performance, with a 3-year return of 200% compared to the Sensex's 35.37%.

Read More

Why is Kingfa Science falling/rising?

04-Dec-2025

As of 04-Dec, Kingfa Science & Technology (India) Ltd's stock price is at 3,992.00, down 1.52% and has declined 10.24% over the last four days. Despite strong year-to-date performance and positive long-term fundamentals, recent trends indicate bearish sentiment and a significant short-term decline.

As of 04-Dec, Kingfa Science & Technology (India) Ltd's stock price is falling, currently at 3,992.00, reflecting a decrease of 61.55 points or 1.52%. The stock has been on a downward trend, having underperformed its sector by 2.18% today and experiencing a consecutive fall over the last four days, resulting in a total decline of 10.24% during this period. <BR><BR>In the past week, the stock has dropped by 8.47%, while the benchmark Sensex has only decreased by 0.53%. Over the last month, Kingfa's stock has fallen by 12.34%, contrasting with a 2.16% increase in the Sensex. Although the stock has shown strong performance year-to-date with a gain of 12.80% and a remarkable 195.70% increase over the past three years, the recent short-term performance indicates a significant decline.<BR><BR>Despite the current downturn, there are positive factors that could stabilize the stock in the long run. The company maintains a low debt-to-equity ratio of 0.04, indicating financial stability. Additionally, it has demonstrated healthy growth in net sales and operating profit, with annual growth rates of 25.94% and 80.77%, respectively. Institutional investors have also increased their stake by 10.03% in the last quarter, suggesting confidence in the company's fundamentals.<BR><BR>However, the immediate price decline can be attributed to the recent negative performance trends and the stock's current positioning below several moving averages, which may indicate bearish sentiment among investors.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0.04 times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 25.94% and Operating profit at 80.77%

 
3

Flat results in Sep 25

 
4

With ROE of 21.6, it has a Fair valuation with a 7.4 Price to Book Value

5

Increasing Participation by Institutional Investors

6

Consistent Returns over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Plastic Products - Industrial

stock-summary
Market cap

INR 5,353 Cr (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

223

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

21.61%

stock-summary
Price to Book

7.42

Revenue and Profits:
Net Sales:
466 Cr
(Quarterly Results - Sep 2025)
Net Profit:
41 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.77%
0%
-6.77%
6 Months
20.55%
0%
20.55%
1 Year
18.44%
0%
18.44%
2 Years
69.56%
0.43%
69.99%
3 Years
193.9%
0.81%
194.71%
4 Years
315.92%
0.75%
316.67%
5 Years
641.09%
1.75%
642.84%

Latest dividend: 10 per share ex-dividend date: Sep-17-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Is Kingfa Science overvalued or undervalued?

Current Valuation Metrics and Financial Health

Kingfa Science’s price-to-earnings (PE) ratio stands at approximately 34.9, which is moderate within its sector context. The price-to-book (P/B) value is 7.53, indicating that the market values the company at over seven times its book value. Enterprise value (EV) multiples such as EV to EBIT and EV to EBITDA are 26.76 and 23.91 respectively, reflecting a premium but not excessive valuation relative to earnings before interest and taxes or depreciation.

The company’s return on capital employed (ROCE) is a robust 27.19%, while return on equity (ROE) is 21.61%, signalling efficient capital utilisation and strong profitability. These figures suggest that Kingfa Science is generating solid returns for shareholders, which suppor...

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2025 | Source : BSE

Newspaper Advertisements - Unaudited Standalone Financial Results for the quarter and half year ended September 30 2025.

Change In The Composition Of The Board Committees

12-Nov-2025 | Source : BSE

Board at its meeting held on 12/11/2025 approved the change in the composition of the Board Committees.

Performance Update Q2-FY 2025-26

12-Nov-2025 | Source : BSE

Performance Update Q2-FY 2025-26

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kingfa Science & Technology (India) Ltd has declared 100% dividend, ex-date: 17 Sep 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Kingfa Science & Technology (India) Ltd has announced 18:91 rights issue, ex-date: 09 Mar 17

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
25.94%
EBIT Growth (5y)
80.77%
EBIT to Interest (avg)
22.30
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
2.26
Tax Ratio
26.04%
Dividend Payout Ratio
9.88%
Pledged Shares
0
Institutional Holding
16.52%
ROCE (avg)
17.68%
ROE (avg)
13.99%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
223
Price to Book Value
7.42
EV to EBIT
26.38
EV to EBITDA
23.57
EV to Capital Employed
7.26
EV to Sales
2.95
PEG Ratio
7.09
Dividend Yield
NA
ROCE (Latest)
27.19%
ROE (Latest)
21.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (6.55%)

FIIs

Held by 7 FIIs (7.78%)

Promoter with highest holding

Kingfa Sci. And Tech. Co. Ltd (67.02%)

Highest Public shareholder

Sbi Mutual Fund (6.55%)

Individual Investors Holdings

13.47%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.81% vs -1.62% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 3.39% vs -5.04% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "465.69",
          "val2": "461.93",
          "chgp": "0.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.60",
          "val2": "57.92",
          "chgp": "4.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.83",
          "val2": "1.19",
          "chgp": "-30.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "41.14",
          "val2": "39.79",
          "chgp": "3.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.01%",
          "val2": "12.54%",
          "chgp": "0.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 11.12% vs 21.07% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 6.03% vs 18.08% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "927.62",
          "val2": "834.77",
          "chgp": "11.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "118.51",
          "val2": "113.28",
          "chgp": "4.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.02",
          "val2": "2.68",
          "chgp": "-24.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.93",
          "val2": "76.33",
          "chgp": "6.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.78%",
          "val2": "13.57%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.71% vs 4.41% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.72% vs 98.64% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,275.14",
          "val2": "1,083.30",
          "chgp": "17.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "164.62",
          "val2": "132.45",
          "chgp": "24.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.15",
          "val2": "3.78",
          "chgp": "9.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "110.96",
          "val2": "88.97",
          "chgp": "24.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.91%",
          "val2": "12.23%",
          "chgp": "0.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 17.27% vs 5.99% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 24.76% vs 50.50% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,744.69",
          "val2": "1,487.72",
          "chgp": "17.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "225.07",
          "val2": "185.14",
          "chgp": "21.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.66",
          "val2": "5.61",
          "chgp": "18.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "152.86",
          "val2": "122.52",
          "chgp": "24.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.90%",
          "val2": "12.44%",
          "chgp": "0.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
465.69
461.93
0.81%
Operating Profit (PBDIT) excl Other Income
60.60
57.92
4.63%
Interest
0.83
1.19
-30.25%
Exceptional Items
0.00
0.00
Standalone Net Profit
41.14
39.79
3.39%
Operating Profit Margin (Excl OI)
13.01%
12.54%
0.47%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.81% vs -1.62% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 3.39% vs -5.04% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
927.62
834.77
11.12%
Operating Profit (PBDIT) excl Other Income
118.51
113.28
4.62%
Interest
2.02
2.68
-24.63%
Exceptional Items
0.00
0.00
Standalone Net Profit
80.93
76.33
6.03%
Operating Profit Margin (Excl OI)
12.78%
13.57%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 11.12% vs 21.07% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 6.03% vs 18.08% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,275.14
1,083.30
17.71%
Operating Profit (PBDIT) excl Other Income
164.62
132.45
24.29%
Interest
4.15
3.78
9.79%
Exceptional Items
0.00
0.00
Standalone Net Profit
110.96
88.97
24.72%
Operating Profit Margin (Excl OI)
12.91%
12.23%
0.68%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 17.71% vs 4.41% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 24.72% vs 98.64% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
1,744.69
1,487.72
17.27%
Operating Profit (PBDIT) excl Other Income
225.07
185.14
21.57%
Interest
6.66
5.61
18.72%
Exceptional Items
0.00
0.00
Standalone Net Profit
152.86
122.52
24.76%
Operating Profit Margin (Excl OI)
12.90%
12.44%
0.46%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 17.27% vs 5.99% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 24.76% vs 50.50% in Mar 2024

stock-summaryCompany CV
About Kingfa Science & Technology (India) Ltd stock-summary
stock-summary
Kingfa Science & Technology (India) Ltd
Small Cap
Plastic Products - Industrial
Kingfa Science & Technology (India) Limited was formerly incorporated as 'Hydro S&S Industries Limited' in November, 1983. The Company was renamed from Hydro S&S Industries Limited to Kingfa Science & Technology (India) Limited in December, 2015. The Company is a subsidiary company of M/s Kingfa Science & Technology Co. Ltd. China.
Company Coordinates stock-summary
Company Details
Dhun Building III Floor, 827 Anna Salai Chennai Tamil Nadu : 600002
stock-summary
Tel: 91-44-28521736 (4 lines)
stock-summary
cs@kingfaindia.com
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai